Rapport Therapeutics, Inc. RAPP Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s operating lease liabilities (current)?
- Rapport Therapeutics, Inc. (RAPP) reported operating lease liabilities (current) of $2.62M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s operating lease liabilities (current) changed year-over-year?
- Rapport Therapeutics, Inc.'s operating lease liabilities (current) increased by 159.4% year-over-year, from $1.01M to $2.62M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s operating lease liabilities (current)?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s operating lease liabilities (current) has grown at a 102.8% compound annual growth rate (CAGR), from $670K to $2.76M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.